Institutional investors control 40.51% of the outstanding shares in GERN. This represents a greater percentage of ownership than at almost any other company in the Biotechnology industry. Additionally, during the quarter ended September 2016, these large investors purchased a net $1.2 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
BLACKROCK FUND ADVISORS Bought 840.4 Thousand shares of Geron Corp
SUSQUEHANNA FINANCIAL GROUP LLLP Bought 728.2 Thousand shares of Geron Corp
MORGAN STANLEY & CO. LLC Bought 451.1 Thousand shares of Geron Corp